🟢 Tier 1: High Priority

Tier 1 KOLs are the most influential, recognized globally or nationally. They often hold senior academic or industry positions and lead major research or therapeutic advancements.

Role: Key in shaping therapeutic guidelines globally, leading pivotal trials, and driving broad adoption of new practices or products.

🟡 Tier 2: Medium Priority

Tier 2 KOLs have substantial regional or national influence and are known for notable contributions within specific therapeutic areas.

Role: Involved in national advisory boards, instrumental in regional education, and pivotal in regional strategy execution and opinion shaping.

🟠 Tier 3: Emerging Priority

Definition: Tier 3 KOLs are recognized as rising experts who are building their reputation through active research, clinical trials, or participation in professional bodies.

Role: Crucial for local-level influence, providing fresh insights into evolving practices, and are targets for developmental initiatives to enhance their trajectory and influence.